These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 11561935

  • 1. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [Abstract] [Full Text] [Related]

  • 2. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C, Group for the Study of Risperidone in Affective Disorders (GSRAD).
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [Abstract] [Full Text] [Related]

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Oct; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 4. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR.
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
    Janicak PG, Keck PE, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM.
    J Clin Psychopharmacol; 2001 Aug; 21(4):360-8. PubMed ID: 11476119
    [Abstract] [Full Text] [Related]

  • 6. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain.
    Vieta E, Herraiz M, Parramon G, Goikolea JM, Fernández A, Benabarre A.
    J Affect Disord; 2002 Oct; 72(1):15-9. PubMed ID: 12204313
    [Abstract] [Full Text] [Related]

  • 7. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS, Bahk WM, Jon DI, Chung SK, Lee SY, Ahn YM, Pae CU, Cho HS, Kim JG, Hwang TY, Lee HS, Min KJ, Lee KU, Yoon BH.
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [Abstract] [Full Text] [Related]

  • 8. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
    Bowden CL, Myers JE, Grossman F, Xie Y.
    J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
    [Abstract] [Full Text] [Related]

  • 9. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL.
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L.
    BMC Psychiatry; 2011 Oct 28; 11():171. PubMed ID: 22034906
    [Abstract] [Full Text] [Related]

  • 12. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
    Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.
    Int Clin Psychopharmacol; 2006 Jan 28; 21(1):11-20. PubMed ID: 16317312
    [Abstract] [Full Text] [Related]

  • 13. Acute and continuation risperidone monotherapy in mania.
    Vieta E, Brugué E, Goikolea JM, Sánchez-Moreno J, Reinares M, Comes M, Colom F, Martínez-Arán A, Benabarre A, Torrent C.
    Hum Psychopharmacol; 2004 Jan 28; 19(1):41-5. PubMed ID: 14716711
    [Abstract] [Full Text] [Related]

  • 14. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May 28; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

  • 15. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr 28; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 16. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM, Keck PE, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F.
    Am J Psychiatry; 2004 Jun 28; 161(6):1057-65. PubMed ID: 15169694
    [Abstract] [Full Text] [Related]

  • 17. Risperidone in combination with mood stabilizers for acute mania: a multicentre, open study.
    Bahk WM, Yoon JS, Kim YH, Lee YH, Lee C, Kim KS, Song HK, Choi SK, Pae CU.
    Int Clin Psychopharmacol; 2004 Sep 28; 19(5):299-303. PubMed ID: 15289703
    [Abstract] [Full Text] [Related]

  • 18. Role of risperidone in bipolar II: an open 6-month study.
    Vieta E, Gastó C, Colom F, Reinares M, Martínez-Arán A, Benabarre A, Akiskal HS.
    J Affect Disord; 2001 Dec 28; 67(1-3):213-9. PubMed ID: 11869771
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD, Wang CH, Shwarz M, Shults J.
    J Affect Disord; 2009 Jan 28; 112(1-3):219-30. PubMed ID: 18486235
    [Abstract] [Full Text] [Related]

  • 20. 1-year follow-up of patients treated with risperidone and topiramate for a manic episode.
    Vieta E, Goikolea JM, Olivares JM, González-Pinto A, Rodriguez A, Colom F, Comes M, Torrent C, Sánchez-Moreno J.
    J Clin Psychiatry; 2003 Jul 28; 64(7):834-9. PubMed ID: 12934986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.